First human face transplantation: 5 years outcomes

Transplantation

Volumn 93, Issue 2, 2012, Pages 236-240

  Petruzzo, Palmina ^a,b   Testelin, Sylvie ^c   Kanitakis, Jean ^a   Badet, Lionel ^a   Lengelé, Benoit ^d   Girbon, Jean Pierre ^a   Parmentier, Hélène ^e   Malcus, Christophe ^a   Morelon, Emmanuel ^a,f   Devauchelle, Bernard ^b   Dubernard, Jean Michel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

Composite tissue allotransplantation; Face allotransplantation; Functional recovery; Immunosuppression side effects; Rejection

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; HLA ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BACTERIAL PNEUMONIA; BONE MARROW TRANSPLANTATION; CASE REPORT; CHEEK; CHIN; CHOLANGITIS; CLINICAL PROTOCOL; CREATININE CLEARANCE; DRUG RECHALLENGE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMOTION; ESTHETICS; FACIAL EXPRESSION; FACIAL TRANSPLANTATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL RECOVERY; GRAFT REJECTION; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY DYSFUNCTION; KISSING; LIP; LIPID BLOOD LEVEL; LIVER BIOPSY; MASTICATION; NOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL BIOPSY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERCEPTIVE DISCRIMINATION; PHONATION; PHOTOCHEMOTHERAPY; POUTING; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTECTION; RISK BENEFIT ANALYSIS; SOCIAL INTERACTION; SWALLOWING; THROMBOTIC THROMBOCYTOPENIC PURPURA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

ADULT; CREATININE; FACIAL TRANSPLANTATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LYMPHOCYTE SUBSETS; MAGNETIC RESONANCE IMAGING; TIME FACTORS;

EID: 84855847308     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823d4af6     Document Type: Article

References (13)

1. Hurlburt M. Facial transplantation: Understanding the interests of patients and hurdles to informed consent. Med Sci Monit 2007; 13: Ra147.
2. Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: Early report. Lancet 2006; 368: 203.
3. Dubernard JM, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation.NEngl J Med 2007; 357: 2451.
4. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008; 372: 631.
5. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma:A1-year follow-up study. Lancet 2008; 372: 639.
6. Siemionow M, Papay F, Alan D, et al. First US near-total human face transplantation-Aparadigmshift for massive facial injuries. Lancet 2009; 374: 203.
7. Pomahac B, Prizab J, Eriksson E, et al. Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 2011; 10: 1.
8. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1398.
9. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2011; 11: 1.
10. Ricordi C, Karatzas T, Nery J, et al. High-dose bone marrow infusions to enhance allograft survival: The effect of timing. Transplantation 1997; 63: 7.
11. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+regulatory T cells. Blood 2005; 105: 4743.
12. Hequet O, Morelon E, Bourgeot JP, et al. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor. Bone Marrow Transplant 2008; 41: 1059.
13. Pantano F, Santini D, Guida F, et al. Potential role of everolimus in inducing cholestasis. Ann Oncol 2010; 21: 433.